Pain assessment conditions the quality of the therapeutic process in a context reshaped by the 2020 International Association for the Study of Pain (IASP) definitional update, the 2017 introduction of the nociplastic mechanistic descriptor, and the recognition of chronic primary pain as an autonomous nosological entity in the International Classification of Diseases, 11th Revision (ICD-11). In this scenario, we conducted a structured narrative review of hybrid architecture, conceived as an instrument mapping review with the deliberate incorporation of elements proper to systematic reviews of measurement instruments, following the Scale for the Assessment of Narrative Review Articles (SANRA) and the principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A systematized search was performed across seven databases (PubMed/MEDLINE, Cochrane Library, Embase, Scopus, PsycINFO, CINAHL, and BVS-LILACS) from January 2000 to February 2026, complemented by hand-searching the guidelines of the main international algological societies (IASP, Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials IMMPACT, American Geriatrics Society AGS, European Pain Federation (EFIC), Society of Critical Care Medicine SCCM/Pain, Agitation/Sedation, Delirium, Immobility, Sleep PADIS, Institute for Clinical Systems Improvement ICSI). The research question was structured according to the COnsensus-based Standards for the selection of health Measurement INstruments guidelines for patient-reported outcome measure (COSMIN-PROM) framework, and the 79 included studies were critically appraised using a principal evaluative core (COSMIN Risk of Bias, A MeaSurement Tool to Assess systematic Reviews, version 2 AMSTAR-2, and Quality Assessment of Diagnostic Accuracy Studies, version 2 QUADAS-2), complemented by RoB 2, ROBINS-I, and AGREE II for the corresponding subsets, with additional calculation of derived diagnostic indices (positive and negative likelihood ratios, diagnostic odds ratio, and Youden index) for screening scales. Instruments were organized in a four-axis operational taxonomy comprising unidimensional intensity scales, multidimensional scales, neuropathic pain-specific scales, pediatric scales, observational scales for non-communicative critically ill patients, observational scales for cognitive impairment and dementia, functional and quality-of-life scales, and psychological scales. The majority of the psychometric studies included (63% per COSMIN Risk of Bias) exhibited low risk of bias, while the principal psychometric deficits concentrated in the limited discriminant validity of neuropathic screening scales vs. nociplastic pain, the insufficient responsiveness evidence in observational geriatric scales, and the heterogeneity of Spanish and Portuguese cross-cultural adaptations. No universal scale exists; optimal selection depends on clinical context, age, cognitive status, mechanistic descriptor, and evaluation objectives. The multimodal integration of unidimensional instruments with functional, cognitive, and behavioral scales operationalizes the biopsychosocial approach that constitutes the contemporary standard for comprehensive chronic pain assessment. The COSMIN-compliant adaptation and revalidation of key instruments in Ibero-American populations constitutes a translational research priority.
Quintero et al. (Sun,) studied this question.